Respiratory systems abnormalities and clinical milestones for patients with amyotrophic lateral sclerosis with emphasis upon survival

References

• Rowland L. P., Shneider N. A. Amyotrophic lateral sclerosis. N Engl J Med 2001; 344: 1688–701
   PubMed Web of Science ®Google Scholar
• World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997; 277: 925–6
   PubMed Web of Science ®Google Scholar
• Brooks B. R., Miller R. B., Swash M., Munsat T. L. For the Worldwide Federation of Neurology research Group on Motor Neuron Disease. El Escorial Revisited: Revised Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. ALS 2000; 1: 293–9
   Google Scholar
• American Thoracic Society. ATS: Standardization of spirometry; 1994 Update. Am J Respir Crit Care Med 1995; 152: 1107–36
   PubMed Web of Science ®Google Scholar
• Knudson R. J., Lebowitz M. D., Holberg J. C., Burrows B. Changes in the normal maximal expiratory flow‐volume curve with growth and aging. Am Rev Respir Dis 1983; 127: 725–34
   PubMed Web of Science ®Google Scholar
• Crapo R. O., Morris A. H., Gardner R. M. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123: 859–64
   Google Scholar
• Dawson‐Saunders B., Trapp R. G. Basic and clinical biostatistics. Norwalk, CT, Appleton & Lange 1990
   Google Scholar
• Lee J. R‐J., Annegers J. F., Appel S. H. Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci 1995; 132: 207–15
   PubMed Web of Science ®Google Scholar
• Chio A., Mora G., Leone M., Mazzini L., Cocito D., Giordana M. T., et al. Early symptom progression rate is related to ALS outcome: a prospective population‐based study. Neurology 2002; 59: 99–103
   PubMed Web of Science ®Google Scholar
• del Aquila M. A., Longstreth W. T., McGuire V., Koepsell T. D., van Belle G. Prognosis in amyotrophic lateral sclerosis: a population based study. Neurology 2003; 60: 813–9
   PubMed Web of Science ®Google Scholar
• Miller R. G., Rosenberg J. A., Gelinas D. F., Mitsumoto H., Newman D., Sufit R., et al. The ALS Practice Parameters Task Force. Neurology 1999; 52: 1311–23
   PubMed Web of Science ®Google Scholar
• Armon C., Moses D. Linear estimates of rates of disease progression as predictors of survival in patients with ALS entering clinical trials. J Neurol Sci 1998; 160((Suppl 1))S37–41
   Google Scholar
• Armon C., Graves M. C., Moses D., Forte D. K., Sepulveda L., Darby S. M., Smith R. A. Linear estimates of disease progression predict survival in patients with amyotrophic lateral sclerosis. Muscle Nerve 2000; 23: 874–82
   PubMed Web of Science ®Google Scholar
• Kaufmann P., Levy G., Thompson J., Delbene M. L., Battista V., Gordon P. H., et al. The ALSFRS‐R predicts survival time in an ALS clinic population. Neurology 2005; 64: 38–43
   PubMed Web of Science ®Google Scholar
• Stambler N., Charatan M., Cedarbaum J., ALS CNTF Treatment Study Group. Prognostic indicators of survival in ALS. Neurology 1998; 50: 66–72
   PubMed Web of Science ®Google Scholar
• Magnus T., Beck M., Giess R., Puls I., Naumann M., Toyka K. V. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve 2002; 25: 709–14
   PubMed Web of Science ®Google Scholar
• Schmidt E. P., Drachman D. B., Wiener C. M., Clawson L., Kimball R., Lechtzin N. Pulmonary predictors of survival in amyotrophic lateral sclerosis: use in clinical trial design. Muscle Nerve 2005, published online 28 October 2005
   Google Scholar
• Czaplinski A., Yen A. A., Appel S. H. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psych 2006; 77: 390–2
   PubMed Web of Science ®Google Scholar
• Schiffman P. L., Belsh J. M. Pulmonary function at diagnosis of amyotrophic lateral sclerosis. Chest 1993; 103: 508–13
   PubMed Web of Science ®Google Scholar
• Heit J. A., Silverstein M. D., Mohr D. N., Petterson T. M., O'Fallon W. M., Melton J. L. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population‐based cohort study. Arch Intern Med 1999; 159: 445–53
   PubMed Web of Science ®Google Scholar
• Silverstein M. D., Heit J. A., Mohr D. N., Petterson T. M., O'Fallon W. M., Melton L. J. Trends in the incidence of deep vein thrombosis and pulmonary embolism. Arch Intern Med 1998; 158: 585–93
   PubMed Web of Science ®Google Scholar
• Heit J. A., Melton J. L. J., Lohse C. M., Petterson T. M., Silverstein M. D., Mohr D. N., O'Fallon W. M. Incidence of venous thromboembolism in hospitalized vs. community residents. Mayo Clin Proc 2001; 76: 1102–11
   PubMed Web of Science ®Google Scholar
• Cushman M., Tsai A. W., White R. H., Heckbert S. R., Rosamond W. D., Enright P., Folsom A. R. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 2004; 117: 19–25
   PubMed Web of Science ®Google Scholar
• Geerst W. H., Pineo G. F., Heit J. A., Berqvist D., Lassen M. R., Colwell C. W., Ray J. G. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: S338–400
   Google Scholar
• Elman L. B., Siderowf A., Houseman G., Kelley M., McCluskey L. F. Venous thrombosis in an ALS population over four years. Amyotrophic Lateral Sclerosis 2005; 6: 246–9
   PubMed Web of Science ®Google Scholar
• Chastre J., Fagon J‐V. State of the Art: Ventilator Associated Pneumonia. Am J Respir Crit Care Med 2002; 165: 867–903
   PubMed Web of Science ®Google Scholar
• Kollef M. H. Prevention of hospital‐associated and ventilator‐associated pneumonia. Crit Care Med 2004; 32: 1396–1405
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Guidelines for the management of adults with hospital‐acquired, ventilator‐associated, and health care‐associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388–416
   PubMed Web of Science ®Google Scholar
• de Carvalho M., Costa J., Swash M. Clinical trials in ALS: a review of the role of clinical and neurophysiological measurements. Amyotrophic Lateral Sclerosis 2005; 6: 202–12
   PubMed Web of Science ®Google Scholar
• Traynor B. J., Alexander M., Corr B., Frost E., Hardiman O. An outcome study of riluzole in amyotrophic lateral sclerosis. J Neurol 2003; 250: 473–9
   PubMed Web of Science ®Google Scholar
• Morgan R. K., McNally S., Alexander M., Conroy R., Hardiman O., Costello R. W. Use of sniff nasal‐inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 2005; 171: 269–74
   PubMed Web of Science ®Google Scholar
• Cedarbaum J. M., Stambler N., Malta E., Fuller C., Hilt D., Thurmond B., Nakanishi A., BDNF ALS Group (Phase III). The ALSFRS‐R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 1999; 169: 13–21
   PubMed Web of Science ®Google Scholar
• Mustfa N., Walsh E., Bryant V., Lyall R. J., Addington‐Hall J., Goldstein L. H., et al. The effect of non‐invasive ventilation on ALS patients and their care givers. Neurol 2006; 66: 1211–7
   PubMed Web of Science ®Google Scholar